Placebo for MK-8892

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Pulmonary Arterial Hypertension

Phase 1

A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)

CompletedNCT01798849

Merck Sharp & Dohme LLCPulmonary Arterial Hypertension

Start: 2013-03-15End: 2013-07-17Updated: 2019-07-22

Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)

CompletedNCT01926509

Merck Sharp & Dohme LLCPulmonary Arterial Hypertension

Start: 2013-11-14End: 2014-09-08Updated: 2018-12-03